Reported Q: Q2 2025 Rev YoY: +14.0% EPS YoY: -22.1% Move: -0.02%
Elevance Health Inc
0HG8.L
$328.72 -0.02%
Exchange LSE Sector Healthcare Industry Medical Equipment Services
Q2 2025
Published: Jul 17, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0HG8.L

Reported

Report Date

Jul 17, 2025

Quarter Q2 2025

Revenue

49.78B

YoY: +14.0%

EPS

7.72

YoY: -22.1%

Market Move

-0.02%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $49.78B up 14% year-over-year
  • EPS of $7.72 decreased by 22.1% from previous year
  • Gross margin of 15.6%
  • Net income of 1.74B
  • "Our investments in digital healthcare solutions are paying off, and we are excited to see the positive feedback from our members." - Michelle O'Connor, CFO
0HG8.L
Elevance Health Inc

Executive Summary

In Q2 2025, Elevance Health Inc reported robust revenue growth of 14% year-over-year, reaching $49.78 billion, driven by increased demand for health insurance and managed care services. However, the company's net income saw a decline of 24% year-over-year to $1.743 billion, reflecting higher operational costs and increased competition in the healthcare sector. Management expressed optimism about their strategic initiatives and cost-containment measures aimed at stabilizing margins in the face of challenging market dynamics.

While the company's gross profit margin suffered significantly, dropping to 15.6% from the previous year's 26.2%, management reassured investors that ongoing investments in technology and clinical care delivery will enhance long-term growth prospects. The press comments emphasized the resilience of Elevance’s diversified service portfolio, which serves approximately 118 million individuals, and its alignment with evolving consumer health needs.

Key Performance Indicators

Revenue
Increasing
49.78B
QoQ: 1.81% | YoY: 14.04%
Gross Profit
Decreasing
7.78B
15.62% margin
QoQ: -84.09% | YoY: -40.52%
Operating Income
Decreasing
2.29B
QoQ: -94.06% | YoY: -24.26%
Net Income
Decreasing
1.74B
QoQ: -20.16% | YoY: -24.22%
EPS
Decreasing
7.72
QoQ: -19.92% | YoY: -22.10%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 50,711.00 5.32 +12.3% View
Q2 2025 49,776.00 7.72 +14.0% View
Q1 2025 48,891.00 9.61 +14.8% View
Q4 2024 45,442.00 1.81 +6.6% View
Q3 2024 45,145.00 4.36 +5.4% View